The biotech sphere has been brimming with activity with respect to Medtronic Plc. Broadly, institutional shareholders dominate the company's ownership makeup by owning 87% of the stock. The company has reported a fizzling performance that outpaces the stock market, signalling a strong position in the sector. There's news of the appointment of the Chief Financial Officer for MiniMed, the name for the planned standalone company that's in the works.
Importantly, Medtronic's MiniMed 780G System has secured European Union approval, making it a game-changer for insulin-requiring diabetics. Medtronic's role in medical devices has been noted as unique; it’s ostensibly a suitable pick for Halal portfolios given its dogged investment in high-yield dividend stocks for 2025 and beyond.
It is also speculated to be the best dividend stock to invest in according to billionaires and a go-to option for a consistent dividend portfolio. The company witnesses a strong finish to this fiscal year with its Q4 results, and announces a dividend increase. Despite execution risks, Medtronic has confirmed its solid presence in the medical device sector.
Medtronic Plc MDT News Analytics from Tue, 05 Nov 2024 08:00:00 GMT to Sat, 26 Jul 2025 08:20:33 GMT - Rating 7 - Innovation 5 - Information 8 - Rumor 3
